Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Approves Sarclisa for Certain Patients with Multiple Myeloma

The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *